These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11453341

  • 21. New developments in the treatment of low high-density lipoprotein cholesterol.
    Miller M.
    Curr Atheroscler Rep; 1999 Jul; 1(1):24-30. PubMed ID: 11122688
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
    Smit JW, Jansen GH, de Bruin TW, Erkelens DW.
    Am J Cardiol; 1995 Jul 13; 76(2):126A-128A. PubMed ID: 7604787
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun 13; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Overviews of fibrate].
    Tada N.
    Nihon Rinsho; 2001 Mar 13; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Goa KL, Barradell LB, Plosker GL.
    Drugs; 1996 Nov 13; 52(5):725-53. PubMed ID: 9118820
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil).
    Farnier M, Bortolini M, Salko T, Freudenreich MO, Isaacsohn JL, Troendle AJ, Gonasun L.
    Am J Cardiol; 2003 Jan 15; 91(2):238-40. PubMed ID: 12521642
    [No Abstract] [Full Text] [Related]

  • 35. Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozil.
    Vergoulas G, Miserlis G, Solonaki F, Imvrios G, Gakis D, Papanikolaou V, Papagiannis A, Visvardis G, Takoudas D, Antoniadis A.
    Transpl Int; 2000 Jan 15; 13 Suppl 1():S64-7. PubMed ID: 11111964
    [Abstract] [Full Text] [Related]

  • 36. [Hypolipidemic agents and their indication].
    Teramoto T.
    Nihon Rinsho; 2001 Mar 15; 59 Suppl 3():559-65. PubMed ID: 11347132
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Use of combination therapy for dyslipidemia: a lipid clinic approach.
    Brown AS.
    Am J Cardiol; 2002 Nov 20; 90(10B):44K-49K. PubMed ID: 12467939
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Gemfibrozil: new aspects in clinical use].
    Tada N.
    Nihon Rinsho; 2001 Mar 20; 59 Suppl 3():625-30. PubMed ID: 11347143
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.